NanOlogy Taps Former Salarius CEO to Accelerate Cancer Drug Trials

source:

[1] NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio (https://finance.yahoo.com/news/nanology-appoi ...)

NanOlogy Taps Former Salarius CEO to Accelerate Cancer Drug Trials

Related News

Babcock & Wilcox Secures $40M Refinery Contract

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes